Commercial Insight: Osteoporosis - Market Players Maximize Revenue Growth Before the Next Challenging Phase Report now Available on ReportsandReports

DALLAS, Texas, June 7, 2010 - ReportsandReports Announce it Will Carry the Commercial Insight
Osteoporosis Market Players Maximize Revenue Growth Before the Next
Challenging Phase Market Research Report (
www.reportsandreports.com/Report/24113/) in its Store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/commercial-insight-osteoporos
is-market-players-maximize-revenu/

(Due to the length of these URLs, it may be necessary to copy and paste
the hyperlinks into your Internet browser's URL address field. Remove the
space if one exists.)

Globally, the osteoporosis market displayed a 3.5% compound annual growth
rate (CAGR) between 2005-09, reaching $9.4 billion in 2009. However, the
launch of generic alendronate in the majority of markets resulted in a
temporary decline in sales during 2009. The market will stabilize during the
next 5 years due to generic incursion and then resume growth from 2015 as new
drugs are launched.

    Scope

    - Analysis of global osteoporosis prescriptions from 2005-09,
      split by geographical region (including emerging markets), drug class,
      and brand.
    - Discussion of key commercial opportunities and threats in the US,
      Japan, and five major European markets.
    - In depth profiles of 13 key osteoporosis brands and pipeline
      agents with SWOT analyses and country-specific sales forecasts to 2019.
    - Detailed analysis of key developer trends, strategies and
      portfolios including a case study of Novartis's Aclasta (zoledronic
      acid).

Highlights

The rest of world, outside of the seven major markets, achieved
osteoporosis-specific sales of $2.4 billion in 2009 with an impressive CAGR
of 8.7% from 2005. Brazil, Russia, India and China were the fastest growing
nations, driving a combined 2005-09 CAGR of 17%.

The osteoporosis market offers multiple opportunities for current and
future market players. In addition to increasing awareness, diagnosis and
treatment, there is the need to develop new drugs that promote bone building.
However, the increase in cost pressure resulting from generic penetration
poses a major barrier to entry.

Leading market players continue to pursue their direct-to-consumer
advertising campaigns, sponsoring events to raise awareness of the disorder
and of respective treatments. Innovative strategies to increase brand loyalty
and confidence, such as risk-sharing schemes, have also been implemented by
Novartis and Sanofi-Aventis.

    Reasons to Purchase

    - Understand historical (2005-09) and future (2010-19)
      osteoporosis drug market dynamics and competitive environment.
    - Gain insight into the main opportunities and threats specific to
      the osteoporosis market.
    - Evaluate the sales forecasts of marketed, generic, and key
      pipeline drugs to 2019 in the US, Japan, France, Germany, Italy,
      Spain, and the UK.

Browse all Healthcare Market Research Reports
( www.reportsandreports.com/market-research/healthcare/ )

Browse all Datamonitor Market Research Reports
( www.reportsandreports.com/Publishers/datamonitor/ )

Browse all Latest Market Research Reports
( www.reportsandreports.com/LatestReport.aspx )

Related Reports

Osteoporosis Market Forecast
www.reportsandreports.com/Report/8193/

Retail Banking Technology Spending Through 2014: Business Function
Segmentation (Interactive Model)
www.reportsandreports.com/Report/7225/

Retail Banking Technology Spending Through 2014: Source Segmentation
(Interactive Model) www.reportsandreports.com/Report/7226/

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth
market research studies of over 5000 micro markets, and 25 industry specific
websites. Our client list boasts almost all well-known publishers of such
reports across the globe. We as a third-party reseller of market research
reports employ a number of marketing tools, such as press releases,
email-marketing and effective search-engine optimization techniques to drive
revenues for our clients. We also provide 24/7 online and offline support
service to our customers.

    Contact:
    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    www.reportsandreports.com/

    reportsnreports.wordpress.com/

Contact: Ms. Sunita, 7557 Rambler road, Suite 727, Dallas, TX 75231, Tel: +1-888-989-8004